Roche will publish its Half Year Results of 2024 prior to the opening of the Swiss Stock Exchange on Thursday, 25 July 2024.

 

07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before)

Release will be e-mailed and posted on the Roche IR website > click here
Presentation slides will be posted on the Roche IR website > click here

 

14:00 – 16:00 CEST / 13:00 – 15:00 BST
08:00 – 10:00 AM EDT / 05:00 - 07:00 AM PDT
The webinar will start with presentations by senior management, followed by a Q&A session.

Presenters:

  • Thomas Schinecker, CEO Roche Group
  • Alan Hippe, Chief Financial and IT Officer Roche
  • Teresa Graham, CEO Roche Pharmaceuticals
  • Matt Sause, CEO Roche Diagnostics 
 

We would like to invite all interested parties to participate in the webinar and to pre-register for the event here.*

Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com.

 

A replay of the webcast will be available via > ir.roche.com
*privacy notice

 

Best regards,

 

 
Bruno Eschli
Head of Investor Relations

 
 
Roche Investor Relations 
Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: bruno.eschli@roche.com

 
Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com

 
Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: birgit.masjost@roche.com

 
 
  
Investor Relations North America 
Loren Kalm
Phone: +1 650 225 3217
e-mail: kalm.loren@gene.com
 

get the latest news and updates to your inbox.